Tumor recurrence in a glioblastoma patient after discontinuation of prolonged temozolomide treatment

There is no consensus regarding the duration of temozolomide (TMZ) treatment for glioblastoma multiforme (GBM). We report a 53-year-old woman who had a left frontal GBM. The tumor showed good response to TMZ treatment, which was discontinued after 5.5 years with recurrence of tumor at the posterior fossa 6 months later, although there was no definite tumor recurrence in the left frontal region. The tumor failed to respond to the reinstitution of TMZ therapy. Continuous TMZ treatment may be necessary in GBM patients on prolonged TMZ treatment despite improved neurological condition and imaging studies revealing marked tumor regression.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Tumor recurrence in a glioblastoma patient after discontinuation of prolonged temozolomide treatment ; volume:12 ; number:04 ; year:2017 ; pages:727-730
Asian journal of neurosurgery ; 12, Heft 04 (2017), 727-730

Contributor
Tseng, Wei-Lung
Hsu, Hsu-Hsien
Chen, Yun
Tseng, Sheng-Hong

DOI
10.4103/ajns.AJNS_39_15
URN
urn:nbn:de:101:1-2022112412324599936314
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Tseng, Wei-Lung
  • Hsu, Hsu-Hsien
  • Chen, Yun
  • Tseng, Sheng-Hong

Other Objects (12)